TY - JOUR
T1 - Endothelial Nicotinic Acetylcholine Receptors and Angiogenesis
AU - Cooke, John P.
AU - Ghebremariam, Yohannes T.
PY - 2008/10
Y1 - 2008/10
N2 - Nicotinic acetylcholine receptors (nAChRs) were first described in non-excitable cells just more than a decade ago. The nAChRs on endothelial cells modulate key angiogenic processes, including endothelial cell survival, proliferation, and migration. The receptors may be stimulated by endogenous agonists such as acetylcholine, or exogenous chemicals such as nicotine, to activate physiologic angiogenesis (such as in wound healing) or pathologic angiogenesis (such as retinal neovascularization or tumor angiogenesis). The endothelial nAChRs may represent a target for therapeutic modulation of disorders characterized by insufficient or pathologic angiogenesis.
AB - Nicotinic acetylcholine receptors (nAChRs) were first described in non-excitable cells just more than a decade ago. The nAChRs on endothelial cells modulate key angiogenic processes, including endothelial cell survival, proliferation, and migration. The receptors may be stimulated by endogenous agonists such as acetylcholine, or exogenous chemicals such as nicotine, to activate physiologic angiogenesis (such as in wound healing) or pathologic angiogenesis (such as retinal neovascularization or tumor angiogenesis). The endothelial nAChRs may represent a target for therapeutic modulation of disorders characterized by insufficient or pathologic angiogenesis.
UR - http://www.scopus.com/inward/record.url?scp=60149109178&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=60149109178&partnerID=8YFLogxK
U2 - 10.1016/j.tcm.2008.11.007
DO - 10.1016/j.tcm.2008.11.007
M3 - Review article
C2 - 19232953
AN - SCOPUS:60149109178
VL - 18
SP - 247
EP - 253
JO - Trends in Cardiovascular Medicine
JF - Trends in Cardiovascular Medicine
SN - 1050-1738
IS - 7
ER -